Finance

Lists
Why is 4893 down 5,95%?
Dive Deeper
4893:TYO
Noile-Immune Biotech Inc
JPÂĄ79,00
-5,95%
(-5,00) 1D
6 Nov., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4893...
Open
JPÂĄ82
High
JPÂĄ83
Low
JPÂĄ79
Mkt. cap
3,54 mjd
Avg. vol.
284,53 k
Volume
346,30 k
52-wk high
JPÂĄ217
52-wk low
JPÂĄ79
EPS
-JPÂĄ17
No. of employees
23
Open
JPÂĄ82
High
JPÂĄ83
Low
JPÂĄ79
Mkt. cap
3,54 mjd
Avg. vol.
284,53 k
Volume
346,30 k
52-wk high
JPÂĄ217
52-wk low
JPÂĄ79
EPS
-JPÂĄ17
No. of employees
23
News stories
From web sources and news partners
About Noile-Immune Biotech Inc
CEO-
Employees23
Founded16 Apr. 2015
Headquarters-
SectorHealth Care
Industry-
Websitenoile-immune.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,00 m
-
-
-
Cost of goods sold
-
52,00 m
-
-
Cost of revenue
-
52,00 m
-
-
Research and development expenses
93,00 m
72,00 m
86,00 m
107,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,00 m
11,00 m
116,00 m
110,00 m
Operating expense
197,00 m
137,00 m
202,00 m
217,00 m
Total operating expenses
197,00 m
189,00 m
202,00 m
217,00 m
Operating income
-196,00 m
-189,00 m
-202,00 m
-217,00 m
Other non operating income
-1,00 m
1,00 m
45,00 m
-1,00 m
EBT including unusual items
-193,00 m
-188,00 m
-153,00 m
-218,00 m
EBT excluding unusual items
-193,00 m
-188,00 m
-153,00 m
-218,00 m
Income tax expense
1,00 m
-
-
1,00 m
Effective tax rate
-0,52%
-
-
-0,46%
Other operating expenses
-
54,00 m
-
-
Net income
-194,00 m
-188,00 m
-153,00 m
-219,00 m
Net profit margin
-19 400,00%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
4,00 m
-
4,00 m
-
Interest expense
-
-
-
-
Net interest expenses
4,00 m
-
4,00 m
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme